HRP20110666T1 - Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti - Google Patents
Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti Download PDFInfo
- Publication number
- HRP20110666T1 HRP20110666T1 HR20110666T HRP20110666T HRP20110666T1 HR P20110666 T1 HRP20110666 T1 HR P20110666T1 HR 20110666 T HR20110666 T HR 20110666T HR P20110666 T HRP20110666 T HR P20110666T HR P20110666 T1 HRP20110666 T1 HR P20110666T1
- Authority
- HR
- Croatia
- Prior art keywords
- oxidopyridin
- cyclopropylmethoxy
- carboxamide
- parkinson
- dichloro
- Prior art date
Links
- 208000019430 Motor disease Diseases 0.000 title claims abstract 4
- 208000018737 Parkinson disease Diseases 0.000 title claims abstract 4
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 title 1
- BRUDLLFMCVQZFT-UHFFFAOYSA-N COC1=CN=C(C(=O)NC=2C(=C[N+]([O-])=CC=2Cl)Cl)C=C1OCC1CC1 Chemical compound COC1=CN=C(C(=O)NC=2C(=C[N+]([O-])=CC=2Cl)Cl)C=C1OCC1CC1 BRUDLLFMCVQZFT-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000002253 acid Substances 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 239000012453 solvate Substances 0.000 claims abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 230000008673 vomiting Effects 0.000 claims 2
- 206010001541 Akinesia Diseases 0.000 claims 1
- 208000012639 Balance disease Diseases 0.000 claims 1
- 206010006100 Bradykinesia Diseases 0.000 claims 1
- 208000019505 Deglutition disease Diseases 0.000 claims 1
- 206010017577 Gait disturbance Diseases 0.000 claims 1
- 208000006083 Hypokinesia Diseases 0.000 claims 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 claims 1
- 206010044565 Tremor Diseases 0.000 claims 1
- 206010047700 Vomiting Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000000095 emetic effect Effects 0.000 claims 1
- 230000001144 postural effect Effects 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 210000005070 sphincter Anatomy 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0702853A FR2915100B1 (fr) | 2007-04-19 | 2007-04-19 | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxalide pour le traitement des desordres moteurs lies a la maladie de parkinson |
| PCT/FR2008/000534 WO2008145841A1 (fr) | 2007-04-19 | 2008-04-16 | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110666T1 true HRP20110666T1 (hr) | 2011-10-31 |
Family
ID=38712405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110666T HRP20110666T1 (hr) | 2007-04-19 | 2011-09-15 | Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US20100130554A1 (es) |
| EP (1) | EP2146714B1 (es) |
| JP (1) | JP5386478B2 (es) |
| KR (2) | KR20150004885A (es) |
| CN (1) | CN101663035B (es) |
| AR (1) | AR066108A1 (es) |
| AT (1) | ATE513548T1 (es) |
| AU (1) | AU2008257322B2 (es) |
| BR (1) | BRPI0810444A2 (es) |
| CA (1) | CA2684174C (es) |
| CL (1) | CL2008001136A1 (es) |
| CY (1) | CY1111840T1 (es) |
| DK (1) | DK2146714T3 (es) |
| EA (1) | EA019194B1 (es) |
| ES (1) | ES2367408T3 (es) |
| FR (1) | FR2915100B1 (es) |
| HK (1) | HK1141725A1 (es) |
| HR (1) | HRP20110666T1 (es) |
| IL (1) | IL201448A (es) |
| JO (1) | JO2678B1 (es) |
| MA (1) | MA31367B1 (es) |
| ME (1) | ME00935B (es) |
| MX (1) | MX2009011284A (es) |
| MY (1) | MY148092A (es) |
| NZ (1) | NZ580482A (es) |
| PA (1) | PA8776801A1 (es) |
| PL (1) | PL2146714T3 (es) |
| PT (1) | PT2146714E (es) |
| RS (1) | RS51869B (es) |
| SI (1) | SI2146714T1 (es) |
| TW (1) | TWI439269B (es) |
| UY (1) | UY31035A1 (es) |
| WO (1) | WO2008145841A1 (es) |
| ZA (1) | ZA200907251B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2892156A1 (en) * | 2012-11-28 | 2014-06-05 | Sanofi | Method of preparation of crystal forms of 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxidopyridyn-4-yl)-5-methoxypyridine-2-carboxamide and cristal forms thereof |
| US9624100B2 (en) | 2014-06-12 | 2017-04-18 | Apple Inc. | Micro pick up array pivot mount with integrated strain sensing elements |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4193926A (en) * | 1974-03-20 | 1980-03-18 | Schering Aktiengesellschaft | 4-(Polyalkoxy phenyl)-2-pyrrolidones |
| DK0711282T3 (da) * | 1993-07-28 | 2002-09-16 | Aventis Pharma Ltd | Forbindelser som PDE IV og TNF inhibitorer |
| US6177077B1 (en) * | 1999-02-24 | 2001-01-23 | Edward L. Tobinick | TNT inhibitors for the treatment of neurological disorders |
| AU770918B2 (en) * | 1999-12-23 | 2004-03-11 | Icos Corporation | Cyclic AMP-specific phosphodiesterase inhibitors |
| HUP0600103A2 (en) * | 2001-03-02 | 2006-06-28 | Bristol Myers Squibb Co | Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| US20060004056A1 (en) * | 2002-07-02 | 2006-01-05 | Bernard Cote | Di-aryl-substituted-ethan pyridone pde4 inhibitors |
| WO2004080422A2 (en) * | 2003-03-12 | 2004-09-23 | Celgene Corporation | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
| EP1888528A2 (en) * | 2005-06-10 | 2008-02-20 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors |
| US20070021451A1 (en) * | 2005-07-20 | 2007-01-25 | Hamamatsu University School Of Medicine | Method for preventing or treating neurologic damage after spinal cord injury |
-
2007
- 2007-04-19 FR FR0702853A patent/FR2915100B1/fr not_active Expired - Fee Related
-
2008
- 2008-04-15 PA PA20088776801A patent/PA8776801A1/es unknown
- 2008-04-16 AU AU2008257322A patent/AU2008257322B2/en not_active Ceased
- 2008-04-16 ME MEP-2009-299A patent/ME00935B/me unknown
- 2008-04-16 KR KR1020147033000A patent/KR20150004885A/ko not_active Application Discontinuation
- 2008-04-16 SI SI200830357T patent/SI2146714T1/sl unknown
- 2008-04-16 CA CA2684174A patent/CA2684174C/fr not_active Expired - Fee Related
- 2008-04-16 MX MX2009011284A patent/MX2009011284A/es active IP Right Grant
- 2008-04-16 WO PCT/FR2008/000534 patent/WO2008145841A1/fr active Application Filing
- 2008-04-16 EP EP08787963A patent/EP2146714B1/fr active Active
- 2008-04-16 AT AT08787963T patent/ATE513548T1/de active
- 2008-04-16 KR KR1020097021593A patent/KR101503942B1/ko not_active IP Right Cessation
- 2008-04-16 ES ES08787963T patent/ES2367408T3/es active Active
- 2008-04-16 NZ NZ580482A patent/NZ580482A/en not_active IP Right Cessation
- 2008-04-16 PT PT08787963T patent/PT2146714E/pt unknown
- 2008-04-16 BR BRPI0810444A patent/BRPI0810444A2/pt not_active IP Right Cessation
- 2008-04-16 MY MYPI20094343A patent/MY148092A/en unknown
- 2008-04-16 EA EA200970970A patent/EA019194B1/ru not_active IP Right Cessation
- 2008-04-16 CN CN2008800126498A patent/CN101663035B/zh not_active Expired - Fee Related
- 2008-04-16 JP JP2010503549A patent/JP5386478B2/ja not_active Expired - Fee Related
- 2008-04-16 RS RS20110358A patent/RS51869B/en unknown
- 2008-04-16 PL PL08787963T patent/PL2146714T3/pl unknown
- 2008-04-16 DK DK08787963.1T patent/DK2146714T3/da active
- 2008-04-17 JO JO2008182A patent/JO2678B1/en active
- 2008-04-17 TW TW097113997A patent/TWI439269B/zh not_active IP Right Cessation
- 2008-04-18 UY UY31035A patent/UY31035A1/es not_active Application Discontinuation
- 2008-04-18 AR ARP080101602A patent/AR066108A1/es unknown
- 2008-04-18 CL CL2008001136A patent/CL2008001136A1/es unknown
-
2009
- 2009-10-05 US US12/573,326 patent/US20100130554A1/en not_active Abandoned
- 2009-10-11 IL IL201448A patent/IL201448A/en not_active IP Right Cessation
- 2009-10-16 ZA ZA2009/07251A patent/ZA200907251B/en unknown
- 2009-11-10 MA MA32333A patent/MA31367B1/fr unknown
-
2010
- 2010-08-31 HK HK10108261.3A patent/HK1141725A1/xx not_active IP Right Cessation
-
2011
- 2011-09-15 HR HR20110666T patent/HRP20110666T1/hr unknown
- 2011-09-15 CY CY20111100887T patent/CY1111840T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009012485A (es) | Formulacion oral de nicotina amortiguada con aminoacidos. | |
| EA201170018A1 (ru) | Разагилин для изменения течения болезни паркинсона | |
| RS53096B (en) | OXAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES | |
| UA99309C2 (ru) | Замещенные пиперидинодигидротиенопиримидины | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| BRPI1014433A2 (pt) | "derivado de um composto ou um sal farmaceuticamente aceitável, composição farmacêutica ou nutracêutica, e métodos para tratar uma condição, para reduzir o desenvolvimento à tolerância a medicamentos vasodilatadores, para estimular a função mitocondrial em células, para melhorar a estrutura ou a função muscular em um animal e os efeitos mitocondriais associados com exercício em um animal, para intensificar a capacidade de exercício em um animal, a saúde e a função muscular, e a recuperação de músculos de atividade vigorosa ou do dano associado com atividade vigorosa ou sustentada em um animal, e, usos de epicatequina ou um derivado de epicatequina, de nicorandil ou um derivado de nicorandil e suas combinações." | |
| GEP20156351B (en) | Glucagon receptor modulator | |
| NZ595046A (en) | Compositions and methods for extended therapy with aminopyridines | |
| JP2012517449A5 (es) | ||
| HRP20131150T1 (hr) | Pimobendan za uporabu u lijeäśenju hipertrofiäśne kardiomiopatije kod maäśaka | |
| HRP20151091T1 (hr) | UPORABA 24-norUDCA | |
| HRP20110666T1 (hr) | Uporaba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju motoričkih poremećaja povezanih s parkinsonovom bolesti | |
| HRP20130205T1 (hr) | Sastavi koji sadrže apoekvorin i postupci njihove uporabe | |
| WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
| HRP20230070T1 (hr) | Tasimelteon za liječenje smith-magenis sindroma | |
| MX2010005205A (es) | Isoformas de neurregulina solubles activas modificadas postraduccionalmente. | |
| EA201390181A1 (ru) | Несущий корпус для лекарственного средства и способ его изготовления | |
| MY167553A (en) | Layered soft palate support and implantation method | |
| CN103349585B (zh) | 磁力阻鼾器及其制造方法 | |
| WO2015103288A3 (en) | Oral exercise appliance | |
| JP2015509934A5 (es) | ||
| JP2010524906A5 (es) | ||
| CN202665764U (zh) | 一种男性外生殖器矫正装置 | |
| BRMU8700162U (pt) | sistema magnético de estabilização do ramo superior e inferior de articuladores | |
| JP3202939U (ja) | 腰痛解消マットレス |